Ulex europeus agglutinin-I binding as a potential prognostic marker in ovarian cancer

Anticancer Research

Volumn 27, Issue 4 C, 2007, Pages 2785-2790

  Blonski, Katharina ^a   Milde Langosch, Karin ^a   Bamberger, Ana Maria ^a   Osterholz, Tina ^a   Utler, Christian ^a   Berger, Jürgen ^a   Löning, Thomas ^a   Schumacher, Udo ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Lectins; Ovarian cancer; Prognosis; UEA I; Ulex europaeus I lectin

Indexed keywords

ULEX EUROPAEUS AGGLUTININ; ULEX EUROPAEUS AGGLUTININ 1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER PATIENT; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LECTIN BINDING; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STAINING; ULEX EUROPAEUS; UNIVARIATE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; BINDING SITES; FEMALE; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; OVARIAN NEOPLASMS; PLANT LECTINS; PROGNOSIS; STAINING AND LABELING;

EID: 34547731568     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Arbeitsgemeinschaft Bevölkerungsbezogener Krebsregister in Deutschland (2004) Krebs in Deutschland. Saarbrücken, fourth edition. http://www.rki.de./GBE/KREBS/KID2004.HTM (17.11.2004)
2. Goldstein I, Hughes R, Monsigny M, Osawa T and Sharon N: What should be called a lectin? Nature 285: 66, 1980.
3. Fenlon S, Ellis I, Bell J, Todd J, Elston C and Blarney R: Helix pomatia and Ulex europeus lectin binding in human breast carcinoma. J Pathol 152: 169-176, 1987.
4. Leathern A and Brooks S: Predictive value of lectin binding on breast-cancer recurrence and survival. Lancet 1: 1054-1056, 1987.
5. Ambros R and Kurman R: Association of Ulex europeus agglutinin I binding with invasion in endometrial carcinoma. Int J Gynecol Pathol 12: 301-306, 1993.
6. Arenas M, Romo E, de Gaspar I, de Bethencourt F, Sanchez-Chapado M, Fraile B and Paniagua R: A lectin histochemistry comparative study in human normal prostate, benign hyperplasia and prostatic carcinoma. Glycoconj 16: 375-382, 1999.
7. Davidson B, Goldberg I, Gotlieb W, Lerner-Geva L, Ben-Baruch G and Kopolovic J: Ulex Europaeus lectin and anti-CD31 staining in squamous cell carcinoma of the uterine cervix: potential prognostic markers. Int J Gynecol Pathol 17: 205-210, 1998.
8. Tavassoli F and Devilee P: Pathology and Genetics. In: Tumours of the Breast and Female Genital Organs. World Health Organization Classification of Tumours. Turn Ovary Peritoneum 6: 114-145, 2002.
9. Kaplan E and Meier P: A non parametric estimate from incomplete observations. J Am Stat Assoc 53: 457-480, 1958.
10. Meier B, Schirmacher P and Klesper B: Expression of lectin binding sites as a prognostic parameter in mouth mucosa carcinomas. Mund Kiefer Gesichtschir 5: 130-135, 2001.
11. Stubbs H, Lih J, Gustafson T and Rice K: Influence of core fucosylation on the flexibility of a biantennary N-linked oligosaccharide. Biochemistry 35: 937-947, 1996.
12. Takahashi T, Ikeda Y, Miyoshi E, Yaginuma Y, Ishikawa M and Tangiguchi N: α-1,6 fucosyltransferase is highly and specifically expressed in human ovarian serous adenocarcinoma. Int J Cancer 88: 914-919, 2000.
13. Wright L, May G, Gregory P, Dyne M, Holmes K, Williams P and Mountford C: Inhibition of metastatic potential by fucosidase: An NMR study identifies a cell surface metastasis marker. J Cell Biochem 37: 49-59, 1988.
14. Xia L, McDaniel J, Yago T, Doeden A and McEver R: Surface fucosylation of human cord blood cells augments binding to P-selectin and E-selectin and enhances engraftment in bone marrow. Blood 104: 3091-3096, 2004.
15. McEver R: Selectin-carbohydrate interactions during inflammation and metastasis. Glycoconj J 14: 585-591, 1997.